Skip to main content
AI Market Summary
Loading market intelligence...

Viela Bio Inc (VIE) Stock Forecast 2025 - AI Price Prediction & Analysis


Viela Bio Inc (VIE) AI Stock Price Forecast & Investment Analysis

Viela Bio Inc Stock Price Chart and Technical Analysis

Loading Viela Bio Inc interactive price chart and technical analysis...

Viela Bio Inc (VIE) - Comprehensive Stock Analysis & Investment Research

Deep dive into Viela Bio Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Viela Bio Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Viela Bio Inc: Viela Bio Inc operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

Viela Bio Inc (Stock Symbol: VIE) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 139 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Viela Bio Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Viela Bio Inc: With $12M in annual revenue and -172.9% net margin, the company demonstrates developing profitability.

Annual Revenue: $12 million generating a -172.9% net profit margin .

Market Capitalization: $2810 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -41.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Viela Bio Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Viela Bio Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Viela Bio Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Viela Bio Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Viela Bio Inc: Market positioning analysis based on available financial and operational metrics.

Viela Bio Inc strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 82.5% gross margin, indicating strong pricing power and operational efficiency.

Viela Bio Inc (VIE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Viela Bio Inc stock analysis.

Loading Viela Bio Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Viela Bio Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Viela Bio Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Viela Bio Inc: With a P/E ratio of -18.73, the market sees the stock as potentially undervalued.

P/E Ratio -18.73x
P/B Ratio 7.75x
Market Cap $2810M
EPS $-2.83
Book Value/Share $6.84
Revenue/Share $0.23
FCF/Share $-2.82
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Viela Bio Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Viela Bio Inc: An ROE of -41.3% indicates room for improvement in shareholder value creation.

ROE -41.3%
ROA -37.3%
ROIC -42.1%
Gross Margin 82.5%
Operating Margin -179.4%
Net Margin -172.9%
EBT Margin -172.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Viela Bio Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Viela Bio Inc: A current ratio of 8.45 indicates strong liquidity.

Current Ratio 8.45x
Quick Ratio 8.10x
Financial Leverage 1.13x
Working Capital $343M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Viela Bio Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Viela Bio Inc: Free cash flow of $-127M indicates cash challenges that need attention.

Operating Cash Flow $-106M
Free Cash Flow $-127M
Capital Spending $-21M
FCF/Sales -212.3%
CapEx/Sales 177.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Viela Bio Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Viela Bio Inc: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Receivables Turnover 0.7x
Fixed Assets Turnover 5.4x
Days Sales Outstanding 554 days
Payables Period 1166 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Viela Bio Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Viela Bio Inc: With annual revenue of $12M, Viela Bio Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $12M
Operating Income $-154M
Net Income $-151M
R&D Expense $887M
SG&A Expense $517M
Cost of Goods Sold $18M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 92%
Cash & Short-term Investments 87%
Total Liabilities 11%
Accounts Receivable 1%
Inventory 0%
Dividend & Shareholder Information
Shares Outstanding 53M

Latest Viela Bio Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Viela Bio Inc (VIE) stock price and investment outlook.

, source: Yahoo Canada Sports

Investors are always looking for stocks that are poised to beat at earnings season and Viela Bio, Inc. VIE may be one such company. The firm has earnings coming up pretty soon, and events are shaping ...

, source: Insider Monkey

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don’t make them change their opinion towards a ...

, source: Law

Viela Bio, a Maryland-based biotechnology company, and other defendants were hit with a securities lawsuit Tuesday in New York Southern District Court. The court case, brought by Rigrodsky Law, ...

Viela Bio Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Viela Bio Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Viela Bio Inc Stock Forecast

How accurate are Viela Bio Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for VIE predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Viela Bio Inc stock price forecasts?

Our analysis considers Viela Bio Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Viela Bio Inc a good investment in 2025?

Based on our AI analysis, Viela Bio Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Viela Bio Inc forecasts updated?

Viela Bio Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Viela Bio Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Viela Bio Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...